Department of Health and Human Services January 27, 2005 – Federal Register Recent Federal Regulation Documents

Proposed Information Collection Activity; Comment Request
Document Number: 05-1521
Type: Notice
Date: 2005-01-27
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
List of Drugs for Which Pediatric Studies Are Needed
Document Number: 05-1495
Type: Notice
Date: 2005-01-27
Agency: Department of Health and Human Services, National Institutes of Health
The National Institutes of Health (NIH) is providing notice of a ``List of Drugs for Which Pediatric Studies Are Needed.'' The NIH developed the list in consultation with the Food and Drug Administration (FDA) and pediatric experts, as mandated by the Best Pharmaceuticals for Children Act. This list adds to the previously published lists prioritizing drugs most in need of study for use by children to ensure the safety and efficacy of their medication. The NIH will update the list at least annually until the Act expires on October 1, 2007.
National Library of Medicine; Notice of Meeting
Document Number: 05-1494
Type: Notice
Date: 2005-01-27
Agency: Department of Health and Human Services, National Institutes of Health
Proposed Data Collections Submitted for Public Comment and Recommendations
Document Number: 05-1493
Type: Notice
Date: 2005-01-27
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Proposed Data Collections Submitted for Public Comment and Recommendations
Document Number: 05-1492
Type: Notice
Date: 2005-01-27
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Correction to a Notice of Meetings
Document Number: 05-1484
Type: Notice
Date: 2005-01-27
Agency: Agency for Healthcare Research and Quality, Department of Health and Human Services
From Concept to Consumer: Center for Biologics Evaluation and Research Working With Stakeholders on Scientific Opportunities for Facilitating Development of Vaccines, Blood and Blood Products, and Cellular, Tissue, and Gene Therapies; Public Workshop; Reopening of the Comment Period
Document Number: 05-1475
Type: Notice
Date: 2005-01-27
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is reopening until January 27, 2006, the comment period for the notice of public workshop and request for comments published in the Federal Register of August 31, 2004 (69 FR 53077). FDA is reopening the comment period to allow interested persons additional time to submit comments and to receive any new information.
Vaccines and Related Biological Products Advisory Committee; Notice of Meeting
Document Number: 05-1474
Type: Notice
Date: 2005-01-27
Agency: Food and Drug Administration, Department of Health and Human Services
Notice of Appeal
Document Number: 05-1452
Type: Notice
Date: 2005-01-27
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
By designation of the Administration for Children and Families, a member of the Departmental Appeals Board has been appointed as the presiding officer for an appeal of the Administration for Children and Families' (ACF) disapproval of an amendment to the plan of the New York State Office of Children and Family Services for implementing title IV-E of the Social Security Act (Foster Care and Adoption Assistance). The purpose of this notice is to give interested parties an opportunity to participate. Requests To Participate: Requests to participate as a party or as amicus curiae must be submitted to the Departmental Appeals Board in the form specified at 45 CFR 213.15 by February 11, 2005. Within that time, those persons, groups, or organizations seeking participation as parties or amici may file petitions or request extensions of time for submitting petitions to participate, and may also contact the Board to obtain copies of the briefs that the parties have filed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.